Dr. Melissa Carpenter becomes ElevateBio’s chief scientific officer of regenerative medicine

ElevateBio appointed Melissa Carpenter, PhD, as chief scientific officer of regenerative medicine Dec. 9.

Advertisement

Four things to know:

1. Dr. Carpenter will aim to forge partnerships with developers of stem-cell based regenerative therapies to expand ElevateBio’s portfolio of companies.

2. She was named as inventor on 34 issued U.S. patents and more than 50 peer reviewed publications in the stem cell field.

3. Most recently, Dr. Carpenter was vice president of research and development at NovoCell, where she brought stem cell research programs to preclinical development.

4. She has more than 25 years of experience in the development of cell therapies using human adult and pluripotent stem cells.

More articles on biologics:
3 orthopedic surgeons to expand services at new Iowa facility
2 recent value-based partnerships for orthopedic procedures
DePuy Synthes recalls devices used in spine fixation system: 6 things to know

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Biologics

Advertisement

Comments are closed.